Rigel Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report
Summary
Rigel Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
Rigel Pharmaceuticals, Inc. (Rigel or 'the company') is a biotechnology company that discovers, develops and provides novel small molecule drugs. Its products are used in immunology, inflammatory, autoimmune, oncology, hematology and immuno-oncology related therapeutic areas. Its products include IgAN, autoimmune hemolytic anemia, and immune thrombocytopenic. The company conducts various clinical trials and receives approval from the US Food and Drug Administration (FDA) before implementing on various patients. Rigel Pharmaceuticals collaborates with various pharmaceutical companies for developing therapeutic drugs. It markets its products through partnerships in various geographical regions including the North America, Europe, and Asia-Pacific. The company is headquartered in South San Francisco, California, the US.
Scope
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook